For Immediate Release
Aaron C. Edmiston
Voting is Now Open for PM360’s 2016 Pharma Choice Awards
Pick Your Favorite Healthcare Creative From the Past Year
NEW YORK, NY, November 21, 2016: Voting is now open for the 2016 PM360 Pharma Choice Awards—the only awards that give everyone within the healthcare industry a chance to select who wins. Now in its eighth year, the Pharma Choice Awards recognize the very best in healthcare creative. The awards are unique in that everyone in the industry gets to act as judges for the approximately 200 entries submitted by their peers.
To vote, go to: https://www.pm360online.com/pharmachoice-vote.
Each voter is allowed to select his or her favorite entry in each of the 14 categories. Those who cast a vote are also automatically entered to win one of two $100 American Express gift cards. The voting website will remain open until December 12th at 9 AM and voters can return to the site more than once to finish choosing their favorites.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.